-
Behavioural scienceInfection and pandemics refines
Bacteraemia resistance and strain trends in Calgary alongside antibiotic prescribing
Population-based Calgary cohort covering five bacteraemia pathogens, 2006 to 2022: fluoroquinolone resistance fell in Gram-positive species, while Escherichia coli ST1193 and CTX-M-27-producing ST131 rose.
Preprint · not peer-reviewed -
Health todayDementia new
Dementia mortality is higher where outdoor ultrafine particle levels are higher
In 2.1 million adults in Montreal and Toronto, each 10,000 particle/cm3 increase in outdoor ultrafine particle concentration was associated with a 22% higher rate of dementia mortality.
Peer-reviewed -
Health todayCancer new
PSMA-guided radiotherapy did not improve failure-free survival in prostate cancer
In a phase 2 trial of 253 men, radiotherapy targeted to every lesion seen on PSMA-PET gave five-year failure-free survival of 66% against 62% for standard care.
Peer-reviewed -
Health todayDementia new
28% of middle-aged and older Canadians know of the hearing loss-dementia link
A survey of 1,404 Canadians found that 28% were aware of the hearing loss-dementia link, and 17% of those aware were more inclined to seek hearing-loss treatment.
Preprint · not peer-reviewed -
Behavioural scienceInfection and pandemics new
Canada's missing measles vaccine coverage figures are filled in by modelling
Researchers curated publicly available Canadian vaccine coverage data and modelled first-dose measles coverage by province, territory and age, then tested the same method against England's more complete records.
Preprint · not peer-reviewed -
Behavioural scienceInfection and pandemics confirms
Infant RSV hospitalisations fell two thirds in Quebec's first nirsevimab season
In Quebec's first season of offering nirsevimab to all infants, hospitalisations with a positive RSV test in those aged 0-5 months fell by 66%, and bronchiolitis emergency visits by 35%.
Peer-reviewed -
Behavioural scienceInfection and pandemics new
Canada's 2025/26 influenza vaccine cut A(H3N2) illness by 38%
In Canada's sentinel outpatient network, the 2025/26 vaccine cut the risk of A(H3N2) illness by 38%, even though most circulating viruses differed from the vaccine strain in laboratory tests.
Preprint · not peer-reviewed -
Behavioural scienceInfection and pandemics refines
Coinfection with respiratory viruses did not worsen COVID-19 in hospitalised children
Among 938 children admitted at Canadian centres that tested every respiratory admission, 18.6% had a viral coinfection, which carried no higher odds of severe COVID-19.
Peer-reviewed
